Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Kuol Awou Foundation
Street 1: Thongping near Universal Printers
Street 2: Thongping near Health Pool Fund
City: Juba
Province: Central Equotoria
Post Code: 4043
Country: South Sudan
Phone: +211926075594
Organization Email: kuolawoufoudation@gmail.com
Web Site: http://www.kafsouthsudan.org
Other Online Presence:

Focal Point Contact Information

Salutation: Lawyer
First Name: Moses
Last Name: Ochola
Title: International Project Development/Fundriasing Officer
Email: futuremoses08@yahoo.com
Phone: +211926075594

Alternate Focal Point Contact Information

Salutation: Dr
First Name: Yong
Last Name: Achuoth
Title: Executive Director
Email: yongachuoth@gmail.com
Phone: +211921688656

General Information

Board Constituency: None
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Other Non-Governmental Organization (NGO)
Organization Description:
Mission Statement:
Kuol Awou Foundation (KAF) is to ensure universal access to high quality, patient centred TB prevention, diagnosis and treatment services for South Sudanese with all forms of TB regardless of geographic location, income, gender, age, religion, tribe, or other affiliation.

We are interested in Tuberculosis because the KAF Founder is the victim of TB.

Our main focus are:

.TB case detection and treatment
.Health
.Nutrition
.WASH
.Education


> We have strengthened promotion of School Health & Community on TB.

>Increase in case notification and detection.
>Increase treatment success rates .

> To improve data quality for better decision making
> KAF did assessment on TB in Bor Community and we supporting Bor Hospital with drugs,paying health workers and volunteers.
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Advocacy
Civil Society and Community Engagement
Delivery of health services and care
Provision of drugs, diagnostics and commodities
Research and Development
Working on Key Populations related to TB

Other Organization Information

Total number of staff in your organization: 26 - 50
Number of full-time staff who are directly involved with TB: 11 - 25
Number of part-time staff who are directly involved with TB: 6 - 10
Number of volunteers who are directly involved with TB: 11 - 25
 
How did you hear about the Stop TB Partnership: Attendance at a TB related event
If you were informed or referred by another partner of the Stop TB Partnership please tell us who: CCM
Why do you wish join the Stop TB Partnership: Network with other partners
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
We are running awareness in SSBC TV,ALJAZEERA ARABIC TV,YOUTUBE and Local Radio Stations in South Sudan
 

Geographical Reach

Which country is your headquarters located in: South Sudan
Which countries do you do operate in:
(This includes countries you are conducting activities in)
South Sudan

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
We are running TB advertisement on SSBC TV,ALJAZEERA ARABIC TV,and local Radio stations
. Ensure high-quality treatment of all diagnosed cases of TB.
. Strengthen human resource development for TB control in the context of overall health workforce development.
. Early case detection through quality-assured diagnosis.


Drug-Resistant TB:
. Scale up access to testing for
resistance to first-line anti-TB drugs among TB
patients.
. Scale up access to testing of
susceptibility to second-line anti-TB drugs, as
well as HIV testing among confirmed cases of
. Scale up access to effective treatment
for drug-resistant TB.



TB-HIV:
. Scale up the implementation of
measures for TB infection control in health care
facilities providing services to people living with
HIV.
. Scale up TB screening among
people living with HIV, according to international
guidelines.
. Scale up access to ART for HIV-
positive TB patients according to international
guidelines

Laboratory Strengthening:
. Increase access to quality-assured AFB microscopy with effective external quality assurance (EQA).
. Increase access to rapid laboratory diagnosis of drug-resistant TB among TB patients
considered at risk of M/XDR-TB.
.

New Diagnostics:
. Address existing knowledge gaps obstructing development of new diagnostic tools
. Evaluate the portfolio of new diagnostic tools, demonstrate patient benefit and predict likely impact
.

New TB Drugs:
. Increase discovery research in order to substantially expand the pipeline of new TB
drug candidates.
. Build and maintain the trial site capacity necessary to support trials for drug-sensitive and drug-resistant TB, as well as latent TB infection


New TB Vaccines:
. Maintain a robust TB vaccine pipeline by supporting research and discovery.
. Build support for TB vaccine development and uptake through advocacy, communications and resource mobilization

Fundamental Research:
. Define critical questions that must be addressed to expedite development of new tools
for TB control

Research:
. Improve access to and use of diagnostic services to increase early TB case-
detection and improve the diagnosis of drug-sensitive and -resistant TB, and TB/HIV co-
infection.
. Improve implementation of joint TB/HIV control activities at the global, regional and
national levels.



Declaration

Declaration of interests:
Yes

Application date: November 6, 2018
Last updated: November 19, 2018